AI-generated draft from CMS source. Review and verify clinical accuracy before use.

CLINICAL STAGE / CARE PATHWAY

Patient is currently in the therapeutic intervention phase of care for symptomatic osteoarthritis (OA) of the knee, with persistent pain affecting functional activities such as ambulation and prolonged standing despite completing an adequate trial of conservative management. Progression to intra-articular hyaluronic acid (HA) injection therapy is clinically consistent with meeting medical necessity criteria for viscosupplementation.

– Sequencing logic: HA injections are considered after failure or contraindication of at least 3 months of conservative therapy (non-pharmacologic and pharmacologic) and failure or contraindication to intra-articular glucocorticoid injections.

ICD-10 / DIAGNOSIS SUPPORT

Diagnosis support includes documented primary or secondary osteoarthritis of the knee confirmed by radiographic evidence such as joint space narrowing, subchondral sclerosis, osteophytes, or subchondral cysts.

The documented diagnosis corresponds with the patient's symptoms, functional impairment, and imaging findings consistent with knee OA.

– Example ICD-10 options:
M17.0 – Bilateral primary osteoarthritis of knee
M17.11 – Unilateral primary osteoarthritis, right knee
M17.12 – Unilateral primary osteoarthritis, left knee
M17.2 – Bilateral post-traumatic osteoarthritis of knee
M17.31 – Unilateral post-traumatic osteoarthritis, right knee
M17.32 – Unilateral post-traumatic osteoarthritis, left knee
M17.4 – Other bilateral secondary osteoarthritis of knee
M17.5 – Other unilateral secondary osteoarthritis of knee

SUBJECTIVE / HPI SUPPORT

Patient reports chronic knee pain attributed to osteoarthritis, describing pain that interferes with ambulation, prolonged standing, and activities of daily living despite prior conservative treatments. Pain is described as persistent, limiting function, and contributing to reduced quality of life.

– Edit if needed:
right knee pain
left knee pain
bilateral knee pain
greater than 3 months

CONSERVATIVE CARE / PRIOR TREATMENT

Patient has completed a documented trial of at least 3 months of conservative therapy, including physical therapy, physician-directed home exercise program, activity modification, NSAID or acetaminophen use, or other non-pharmacologic treatments, without adequate relief.

Patient has experienced failure of or has contraindications to intra-articular glucocorticoid injections to manage knee OA symptoms.

– Common conservative care examples:
Physical therapy
Home exercise program
Weight management
Knee bracing
NSAID therapy
Topical capsaicin
Intra-articular corticosteroid injections (failed or contraindicated)

OBJECTIVE / DIAGNOSTIC SUPPORT

Physical examination reveals clinical signs consistent with knee OA, including joint line tenderness, crepitus, or decreased range of motion.

Radiographic imaging confirms osteoarthritic changes in the knee joint such as joint space narrowing, osteophyte formation, subchondral sclerosis, or cysts.

No alternative pathology better explains the patient’s symptoms.

ASSESSMENT

Assessment: Symptomatic osteoarthritis of the knee with documented functional impairment and pain refractory to conservative management. Radiographic and clinical findings support medical necessity for intra-articular hyaluronic acid injection therapy.

PLAN / NEXT STEP

Plan: Proceed with intra-articular injection of hyaluronic acid in the affected knee(s) in accordance with FDA approved dosing and frequency to improve joint function, decrease pain, and delay progression of symptoms. The risks, benefits, and alternatives of viscosupplementation have been discussed with the patient.

– Edit if needed:
right knee
left knee
bilateral knees

PROCEDURE-SPECIFIC CLINICAL REQUIREMENTS

Documented failure of or contraindication to a minimum 3-month trial of conservative management.

Documented failure or contraindication to intra-articular corticosteroid injection.

Radiographic evidence of knee osteoarthritis consistent with diagnosis.

Injection dosing and frequency consistent with FDA approved labeling.

Repeat series of injections may be considered if at least 6 months have elapsed since the prior series and patient experienced clinical improvement previously.

– Documentation tip: Include notes on pain score before and after injections, functional improvement, and duration of symptomatic relief.

FOLLOW-UP / RESPONSE DOCUMENTATION

Patient reports clinically meaningful improvement in knee pain, ambulation, standing tolerance, and overall function following intra-articular hyaluronic acid injection therapy compared to baseline.

Response is consistent with expected outcomes of viscosupplementation per clinical guidelines and literature.

– Edit if needed:
greater than 50% pain improvement
relief lasting several months

MISSING DOCUMENTATION CHECK

– Documentation items to confirm:
Symptom duration
Functional limitation
Prior conservative care trial and response
Contraindication or failure of corticosteroid injections
Radiographic confirmation of OA diagnosis
Injection dosing and frequency documentation
Laterality of knee(s) treated
Pre- and post-injection pain scores and functional assessments

APPEAL / PEER-TO-PEER CLINICAL SUPPORT

The requested intra-articular hyaluronic acid injection is clinically supported by the documented diagnosis of knee OA, persistent functional impairment, failed conservative treatments including corticosteroid injections, and objective imaging findings. The proposed treatment aligns with established clinical guidelines for viscosupplementation and supports medical necessity for progression of care.

Clinical records demonstrate that this therapeutic intervention is consistent with the patient's symptom severity, failed prior care attempts, and functional limitations. Reconsideration is requested based on medical necessity and the documented evidence of benefit from prior treatment series if applicable.

– Common workflow:
Start with conservative management → corticosteroid injection trial or contraindication → radiographic diagnosis confirmed → progression to HA injection series → monitor response → consider repeat series after 6 months if improvement documented.